课题基金 / 基金详情

MECHANISMS OF CARDIOMYOCYTE CELL DEATH BY APOPTOSIS

MECHANISMS OF CARDIOMYOCYTE CELL DEATH BY APOPTOSIS
心肌细胞凋亡的机制
批准号:
6288762
负责人:
MICHAEL T CROW
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

MICHAEL T CROW的其他基金

相似基金

相关文献

中文摘要
翻译
心脏细胞损失发生在急性缺血性损伤、心力衰竭和心脏正常老化过程中。细胞损失主要是由于心肌细胞的死亡,并且在很大程度上由细胞凋亡和称为半胱氨酸蛋白酶的半胱氨酸蛋白酶的激活介导。我们已经表明,心脏和骨骼肌含有一种特异性的半胱天冬酶2和8的抑制剂,称为ARC,并且在培养的心肌细胞和完整的心脏中,ARC的表达在缺血应激期间显著降低。此外,ARC在心肌细胞系中的过表达保护其免于缺血诱导的细胞死亡。保护作用与抑制半胱天冬酶2活化和细胞色素c释放有关,这以半胱天冬酶非依赖性方式发生。我们还表明,各种生长和神经激素因子也提供心肌细胞保护缺血诱导的细胞死亡,通过ARC的独立途径。所有这些因子的共同点是它们能够激活磷脂酰肌醇3-激酶(PI-3 K)活性,直接通过将PI-3 K亚基募集到受体对接位点(IGF-1)或通过Gi依赖性信号传导,例如与β 2-肾上腺素能受体相关的信号传导。因此,PI-3 K的抑制剂阻断各种存活因子的保护作用。目前的研究集中在评估NF-κ B和Forkhead转录因子作为参与细胞存活的PI-3 K活化的可能下游靶点的作用。- 心肌细胞,凋亡,缺血,缺氧,肾上腺素能信号,ARC
英文摘要
SUMMARY OF WORK Cardiac cell loss occurs in response to acute ischemic injury, during heart failure, and during the normal aging of the heart. Cell loss is due predominantly to the death of cardiac myocytes and is mediated in large part by apoptosis and the activation of cysteine proteases known as caspases. We have shown that heart and skeletal muscle contain a specific inhibitor of caspases 2 and 8, known as ARC, and that ARC expression is dramatically reduced during ischemic stress both in cultured myocytes and the intact heart. Furthermore, overexpression of ARC in a heart myogenic cell line protects it from ischemia-induced cell death. Protection is associated with inhibition of caspase 2 activation and cytochrome c release, which occurs in a caspase-independent manner. We have also shown that various growth and neurohormonal factors also provide cardiomyocytes protection from ischemia-induced cell death through ARC-independent pathways. The common element in all such factors is their ability to activate phosphatidylinositol 3-kinase (PI-3K) activity, either directly through recruitment of PI-3K subunits to receptor docking sites (IGF-1) or through Gi-dependent signaling, such as that associated with the beta2- adrenergic receptor. Accordingly, inhibitors of PI-3K block the protective effects of the various survival factors. Current studies are focussed on assessing the role of NF-kB and the Forkhead transcription factors as possible downstream targets of PI-3K activation involved in cell survival. - Cardiomyocytes, Apoptosis, Ischemia, Hypoxia, Adrenergic Signaling, ARC
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determinants of Right Heart Failure In Severe PAH
  • 批准号:
    8013840
  • 项目类别:
  • 资助金额:
    $40.7万
  • 财政年份:
    2010
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
Core--Molecular resources
  • 批准号:
    7347549
  • 项目类别:
  • 资助金额:
    $27.1万
  • 财政年份:
    2007
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
Determinants of Right Heart Failure In Severe PAH
  • 批准号:
    7231194
  • 项目类别:
  • 资助金额:
    $42.14万
  • 财政年份:
    2006
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
ARC REGULATES MITOCHONDRIAL DEATH SIGNALING IN HEART
  • 批准号:
    7093496
  • 项目类别:
  • 资助金额:
    $39.91万
  • 财政年份:
    2004
  • 负责人:
    MICHAEL T CROW
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: